Skip to main content
Integrity IndexIntegrity Index
← Companies
SCYX

SCYNEXIS INC

Data as of Nov 11, 2026
SCYX
CIK 1178253Pharmaceutical Preparations
Federal contracts since 2024
$18M
1 awards · latest Oct 1, 2026

Federal contracts

$18,454,788 in federal contract awards across 1 actions since January 2024, most recently Oct 1, 2026. Amounts are obligated values as reported to USAspending; modifications and de-obligations can be negative.

By agency

  • Department of Health and Human Services$18M1 award

Largest awards

DateAwardAmount
Oct 1, 2026
Department of Health and Human Services
ADVANCE THE DEVELOPMENT OF SCY-247, A NOVEL ANTIFUNGAL CURRENTLY IN PHASE 1 CLINICAL TRIALS, FOR THE TREATMENT OF INVASIVE CANDIDIASIS AND PROPHYLAXIS OF INVASIVE FUNGAL DISEASE AS ORAL AND IC FORMULA
$18,454,788

Data: FEC (PAC contributions, Schedule A), Quiver Quantitative (congressional holdings, lobbying, contracts), Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to SCYNEXIS INC through its SEC registration (CIK 1178253) and tickers SCYX.

As of: contract actions through Oct 1, 2026. Snapshot rebuilt Nov 11, 2026.

Holdings values are estimates from disclosed ranges. PAC contributions cover the current and previous election cycle and count only gifts to sitting members' principal campaign committees, so leadership PACs and losing candidates are not included.